| | | DL-NEOMENTHOL CAS:3623-51-6 Formula: C10H20O GëÑ95% 3623-51-6 Cyclohexanol, 5-methyl-2-(1-methylethyl)-, (1R,2R,5S)-rel-; Cyclohexanol, 5-methyl-2-(1-methylethyl)-, (1+¦,2+¦,5+¦)-(-¦)-; Menthol, trans-1,3,trans-1,4-(-¦)-; rel-(1R,2R,5S)-5-Methyl-2-(1-methylethyl)cyclohexanol; (-¦)-Neomenthol; Cyclohexanol, DL-SERINE-2,3,3-D3 CAS:70094-78-9 Formula: C21H17NO5 95% by HPLC; 98% atom D BLP-009780 DL-Serine-2,3,3-d3;70094-78-9;DL-SERINE (2,3,3-D3);Serine-2,3,3-d3;2-Amino-2,3,3-trideuterio-3-hydroxypropanoic acid;L-Serine-2,3,3-d3;SCHEMBL10874964;HY-Y0507S;(+/-)-Serine-2,3,3-d3;2-amino-3-hydroxy(?H?)propanoic acid;DB-264859;CS-0376467 DL-TETRAHYDROBERBERINE CAS:522-97-4 Formula: C20H21NO4 GëÑ95% B2703-464701 6H-Benzo[g]-1,3-benzodioxolo[5,6-a]quinolizine, 5,8,13,13a-tetrahydro-9,10-dimethoxy-; 5,8,13,13a-Tetrahydro-9,10-dimethoxy-6H-benzo[g]-1,3-benzodioxolo[5,6-a]quinolizine; Berberine, 9-deoxy-16,17-dihydro-; Berbine, 9,10-dimethoxy-2,3-(meth DL-VITAMIN E ACETATE CAS:7695-91-2 Formula: C31H52O3 98% 7695-91-2 2H-1-Benzopyran-6-ol, 3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-, 6-acetate; 2H-1-Benzopyran-6-ol, 3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-, acetate; 6-Chromanol, 2,5,7,8-tetramethyl-2-(4,8,12-trimeth DL-WILLARDIINE CAS:19772-76-0 Formula: C7H9N3O4 95% 19772-76-0 1(2H)-Pyrimidinepropanoic acid, +¦-amino-3,4-dihydro-2,4-dioxo-; 1(2H)-Pyrimidinepropanoic acid, +¦-amino-3,4-dihydro-2,4-dioxo-, (-¦)-; 1(2H)-Pyrimidinepropionic acid, +¦-amino-3,4-dihydro-2,4-dioxo-, DL-; +¦-Amino-3,4-dihydro-2,4-dioxo-1(2H)-p DLIN-KC2-DMA CAS:1190197-97-7 Formula: C43H79NO2 >98% B4059-291966 2,2-Dilinoleyl-4-dimethylaminoethyl-[1,3]-dioxolane; N,N-Dimethyl-2,2-di-(9Z,12Z)-9,12-octadecadien-1-yl-1,3-dioxolane-4-ethanamine; 2,2-Dilinoleyl-4-(2-dimethylaminoethyl)-1,3-dioxolane; 2-[2,2-Di-(9Z,12Z)-octadeca-9,12-dienyl-1,3-dioxolan DLINDMA CAS:871258-12-7 Formula: C41H77NO2 >98% B4059-051365 1,2-dilinoleyloxy-n,n-dimethyl-3-aminopropane; N,N-dimethyl-2,3-bis[(9Z,12Z)-octadeca-9,12-dienoxy]propan-1-amine; N,N-Dimethyl-2,3-bis(((9Z,12Z)-octadeca-9,12-dien-1-yl)oxy)propan-1-amine DM1-SMCC CAS:1228105-51-8 Formula: C51H66ClN5O16S 95% BBF-04656 2,5-dioxopyrrolidin-1-yl 4-((3-((3-(((2S)-1-(((14S,16S,33S,2R,4R,10E,12Z,14R)-86-chloro-14-hydroxy-85,14-dimethoxy-33,2,7,10-tetramethyl-12,6-dioxo-7-aza-1(6,4)-oxazinana-3(2,3)-oxirana-8(1,3)-benzenacyclotetradecaphane-10,12-dien-4-yl)oxy) DM21 CAS:2243689-80-5 Formula: C58H83ClN8O16S BADC-01415 MC-ADAA-S-NCA-DM1; Maytansine, N2'-deacetyl-N2'-[6-[[[[N-[6-(2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl]-L-alanyl-D-alanyl-L-alanyl]amino]methyl]thio]-1-oxohexyl]-; (14S,16S,32S,33S,2R,4S,10E,12E,14R)-86-chloro-14-hydroxy-85,14-dimethoxy-33,2,7,1 DM4-SPDB CAS:1626359-62-3 Formula: C46H63ClN4O14S2 GëÑ98% BADC-00012 (1S,2R,3S,5S,6S,16E,18E,20R,21S)-11-Chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10(26),11,13,16,18-pentaen-6-yl (2 S)-2-{[4-({4-[(2,5-dioxo-1-pyrrolidinyl)oxy DMAB-ANABASEINE DIHYDROCHLORIDE CAS:154149-38-9 Formula: C19H21N3.2HCl GëÑ98% by HPLC 154149-38-9 Benzenamine, 4-[(5,6-dihydro[2,3'-bipyridin]-3(4H)-ylidene)methyl]-N,N-dimethyl-, hydrochloride (1:2); 4-[(5,6-Dihydro[2,3'-bipyridin]-3(4H)-ylidene)methyl]-N,N-dimethylbenzenamine dihydrochloride; Benzenamine, 4-[(5,6-dihydro[2,3'-bipyridi DMAPT CAS:870677-05-7 Formula: C17H27NO3 GëÑ99% BBF-04346 Dimethylamino Parthenolide; NSC-734325; Oxireno(9,10)cyclodeca(1,2-b)furan-9(1ah)-one, 8-((dimethylamino)methyl)-2,3,6,7,7a,8,10a,10b-octahydro-1a,5-dimethyl-, (1aR,4E,7aS,8S,10aS,10bR)- DMDNA31 CAS:845625-44-7 Formula: C50H62N4O13 GëÑ99% 845625-44-7 2,7-(Epoxy[1,11,13]pentadecatrienoimino)-6H-benzofuro[4,5-a]phenoxazine-1,6,15(2H)-trione, 25-(acetyloxy)-10-[4-(dimethylamino)-1-piperidinyl]-5,12,21,23-tetrahydroxy-27-methoxy-2,4,16,20,22,24,26-heptamethyl-, (2S,16Z,18E,20S,21S,22R,23R,2 DMHAPC-CHOL CAS:794494-38-5 Formula: C35H63N2O3 BPG-3624 DMHAPC-Chol; 794494-38-5; 3-[[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxycarbonylamino]propyl-(2-hydroxyethyl)-dimethylazanium; (3bet DMP 323 CAS:151867-81-1 Formula: C35H38N2O5 151867-81-1 Dmp 323;151867-81-1;Dmp-323;XM-323;dmp323;(4r,5s,6s,7r)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis[4-(hydroxymethyl)benzyl]-1,3-diazepan-2-one;KXN3869XB2;(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis[[4-(hydroxymethyl)phenyl]methyl]-1,3-diazepan DMPAC-CHOL CAS:184582-91-0 Formula: C33H58N2O2 BPG-3625 DMPAC-Chol; 184582-91-0; (3beta)-cholest-5-en-3-ol 3-[[3-(dimethylamino)propyl]carbamate]; (3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-((R)-6-methylheptan-2-yl)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren DMU-212 CAS:134029-62-2 Formula: C18H20O4 95% B1370-236170 3,4,5,4'-Tetramethoxystilbene; (E)-3,4,5,4'-Tetramethoxystilbene; 1-(4-Methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene; trans-3,4,5,4'-tetramethoxystilbene; NSC631365; 3,4,4',5-Tetramethoxy-trans-stilbene; 1,2,3-Trimethoxy-5-[(E)-2-(4-metho DNP-PEG10-COOH Formula: C29H49N3O16 GëÑ95% BPG-1593 DNP-NH-PEG10-C2-acid; DNP-PEG10-acid; 1-((2,4-dinitrophenyl)amino)-3,6,9,12,15,18,21,24,27,30-decaoxatritriacontan-33-oic acid DNP-PEG10-COOtBu Formula: C33H57N3O16 GëÑ95% BPG-1599 DNP-NH-PEG10-C2-Boc; DNP-PEG10-t-butyl ester; tert-butyl 1-((2,4-dinitrophenyl)amino)-3,6,9,12,15,18,21,24,27,30-decaoxatritriacontan-33-oate DNP-PEG10-DNP Formula: C34H52N6O18 GëÑ95% BPG-0201 N1,N32-bis(2,4-dinitrophenyl)-3,6,9,12,15,18,21,24,27,30-decaoxadotriacontane-1,32-diamine DNP-PEG10-N3 Formula: C28H48N6O14 GëÑ95% BPG-1623 DNP-PEG10-azide; 32-azido-N-(2,4-dinitrophenyl)-3,6,9,12,15,18,21,24,27,30-decaoxadotriacontan-1-amine DNP-PEG10-NH2 Formula: C28H50N4O14 GëÑ95% BPG-0215 N1-(2,4-dinitrophenyl)-3,6,9,12,15,18,21,24,27,30-decaoxadotriacontane-1,32-diamine DNP-PEG10-NHBoc Formula: C33H58N4O16 GëÑ95% BPG-1648 tert-Butyl (2-(2-(2-(2-(2-(2-(2-(2-(2-(2-(2-((2,4-dinitrophenyl)amino)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethyl)carbamate; tert-butyl (32-((2,4-dinitrophenyl)amino)-3,6,9,12,15,18,21,24,27,30-decaoxadotriac DNP-PEG10-NHS ester Formula: C33H52N4O18 GëÑ95% BPG-1661 2,5-dioxopyrrolidin-1-yl 1-((2,4-dinitrophenyl)amino)-3,6,9,12,15,18,21,24,27,30-decaoxatritriacontan-33-oate DNP-PEG11-COOH Formula: C31H53N3O17 GëÑ95% BPG-0193 DNP-NH-PEG11-C2-acid; DNP-PEG11-acid; 1-((2,4-dinitrophenyl)amino)-3,6,9,12,15,18,21,24,27,30,33-undecaoxahexatriacontan-36-oic acid DNP-PEG11-COOtBu Formula: C35H61N3O17 GëÑ95% BPG-1603 DNP-NH-PEG11-C2-Boc; DNP-PEG11-t-butyl ester; tert-butyl 1-((2,4-dinitrophenyl)amino)-3,6,9,12,15,18,21,24,27,30,33-undecaoxahexatriacontan-36-oate DNP-PEG11-DNP Formula: C36H56N6O19 GëÑ95% BPG-1611 N1,N35-bis(2,4-dinitrophenyl)-3,6,9,12,15,18,21,24,27,30,33-undecaoxapentatriacontane-1,35-diamine DNP-PEG11-N3 Formula: C30H52N6O15 GëÑ95% BPG-1624 DNP-PEG11-azide; 35-azido-N-(2,4-dinitrophenyl)-3,6,9,12,15,18,21,24,27,30,33-undecaoxapentatriacontan-1-amine DNP-PEG11-NH2 Formula: C30H54N4O15 GëÑ95% BPG-0216 N1-(2,4-dinitrophenyl)-3,6,9,12,15,18,21,24,27,30,33-undecaoxapentatriacontane-1,35-diamine DNP-PEG11-NHBoc Formula: C35H62N4O17 GëÑ95% BPG-1651 tert-Butyl (2-(2-(2-(2-(2-(2-(2-(2-(2-(2-(2-(2-((2,4-dinitrophenyl)amino)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethyl)carbamate; tert-butyl (35-((2,4-dinitrophenyl)amino)-3,6,9,12,15,18,21,24,27,30,33-u DNP-PEG11-NHS ester Formula: C35H56N4O19 GëÑ95% BPG-1665 2,5-dioxopyrrolidin-1-yl 1-((2,4-dinitrophenyl)amino)-3,6,9,12,15,18,21,24,27,30,33-undecaoxahexatriacontan-36-oate DNP-PEG11-OH Formula: C28H49N3O15 GëÑ95% BPG-1671 DNP-PEG11-alcohol; 32-((2,4-dinitrophenyl)amino)-3,6,9,12,15,18,21,24,27,30-decaoxadotriacontan-1-ol DNP-PEG12-COOH Formula: C33H57N3O18 GëÑ95% BPG-1589 DNP-NH-PEG12-C2-acid; DNP-PEG12-acid; 1-((2,4-Dinitrophenyl)amino)-3,6,9,12,15,18,21,24,27,30,33,36-dodecaoxanonatriacontan-39-oic acid; 3,6,9,12,15,18,21,24,27,30,33,36-Dodecaoxanonatriacontan-39-oic acid, 1-[(2,4-dinitrophenyl)amino]-; DN DNP-PEG12-COOtBu Formula: C37H65N3O18 GëÑ95% BPG-1601 DNP-NH-PEG12-C2-Boc; DNP-PEG12-t-butyl ester; tert-butyl 1-((2,4-dinitrophenyl)amino)-3,6,9,12,15,18,21,24,27,30,33,36-dodecaoxanonatriacontan-39-oate DNP-PEG12-DNP Formula: C38H60N6O20 GëÑ95% BPG-1613 N1,N38-bis(2,4-dinitrophenyl)-3,6,9,12,15,18,21,24,27,30,33,36-dodecaoxaoctatriacontane-1,38-diamine DNP-PEG12-N3 Formula: C32H56N6O16 GëÑ95% BPG-0204 DNP-PEG12-azide; 38-azido-N-(2,4-dinitrophenyl)-3,6,9,12,15,18,21,24,27,30,33,36-dodecaoxaoctatriacontan-1-amine DNP-PEG12-NH2 Formula: C32H58N4O16 GëÑ95% BPG-0214 N1-(2,4-dinitrophenyl)-3,6,9,12,15,18,21,24,27,30,33,36-dodecaoxaoctatriacontane-1,38-diamine DNP-PEG12-NHBoc Formula: C37H66N4O18 GëÑ95% BPG-1647 tert-Butyl (2-(2-(2-(2-(2-(2-(2-(2-(2-(2-(2-(2-(2-((2,4-dinitrophenyl)amino)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethyl)carbamate; tert-butyl (38-((2,4-dinitrophenyl)amino)-3,6,9,12,15,18,21,24, DNP-PEG12-NHS ESTER Formula: C37H60N4O20 GëÑ95% BP-501946 DNP-NH-PEG(12)-NHS; DNP-PEG12-NHS; 2,5-dioxopyrrolidin-1-yl 1-((2,4-dinitrophenyl)amino)-3,6,9,12,15,18,21,24,27,30,33,36-dodecaoxanonatriacontan-39-oate; 1-({39-[(2,4-Dinitrophenyl)amino]-4,7,10,13,16,19,22,25,28,31,34,37-dodecaoxanonatria DNP-PEG12-OH Formula: C30H53N3O16 GëÑ95% BPG-1674 DNP-PEG12-alcohol; 35-((2,4-dinitrophenyl)amino)-3,6,9,12,15,18,21,24,27,30,33-undecaoxapentatriacontan-1-ol DNP-PEG4-ACID CAS:858126-76-8 Formula: C17H25N3O10 GëÑ95% BP-500250 DNP-NH-PEG4-C2-acid; DNP-PEG4-COOH; DNP-NH-PEG(4)-COOH; 1-((2,4-Dinitrophenyl)amino)-3,6,9,12-tetraoxapentadecan-15-oic acid; 1-(2,4-Dinitrophenylamino)-3,6,9,12-tetraoxapentadecanoic acid; Propanoic acid, 3-[2-[2-[2-[2-[(2,4-dinitrophenyl) DNP-PEG4-COOTBU CAS:1817735-31-1 Formula: C21H33N3O10 GëÑ95% BPG-0199 DNP-PEG4-t-butyl ester; DNP-NH-PEG4-C2-Boc; 4,7,10,13-Tetraoxapentadecanoic acid, 15-[(2,4-dinitrophenyl)amino]-, 1,1-dimethylethyl ester; 2-Methyl-2-propanyl 1-[(2,4-dinitrophenyl)amino]-3,6,9,12-tetraoxapentadecan-15-oate; 3,6,9,12-Tetrao DNP-PEG4-DBCO Formula: C35H39N5O10 0.98 BPG-4251 DNP-PEG4-DBCO; 2149585-17-9; AKOS040743238; BP-24022; HY-140619; CS-0114707; N-(3-{2-azatricyclo[10.4.0.0,]hexadeca-1(12),4,6,8,13,15-hexaen-10-yn-2-yl}-3-oxopropyl)-1-[(2,4-dinitrophenyl)amino]-3,6,9,12-tetraoxapentadecan-15-amide; N-(3-{2 DNP-PEG4-NHS ESTER CAS:858126-78-0 Formula: C21H28N4O12 GëÑ95% BADC-00692 DNP-NH-PEG(4)-NHS; DNP-PEG4-NHS; 1-(2,4-Dinitrophenylamino)-3,6,9,12-tetraoxapentadecanoic acid succinimidyl ester; 2,5-dioxopyrrolidin-1-yl 1-((2,4-dinitrophenyl)amino)-3,6,9,12-tetraoxapentadecan-15-oate; 2,5-Pyrrolidinedione, 1-[3-[2-[2- DNP-PEG6-COOH Formula: C21H33N3O12 GëÑ95% BPG-1591 DNP-NH-PEG6-C2-acid; DNP-PEG6-acid; 1-[(2,4-Dinitrophenyl)amino]-3,6,9,12,15,18-hexaoxahenicosan-21-oic acid; 3,6,9,12,15,18-Hexaoxaheneicosan-21-oic acid, 1-[(2,4-dinitrophenyl)amino]- DNP-PEG6-COOtBu Formula: C25H41N3O12 GëÑ95% BPG-1602 DNP-NH-PEG6-C2-Boc; DNP-PEG6-t-butyl ester; tert-butyl 1-((2,4-dinitrophenyl)amino)-3,6,9,12,15,18-hexaoxahenicosan-21-oate; 2-Methyl-2-propanyl 1-[(2,4-dinitrophenyl)amino]-3,6,9,12,15,18-hexaoxahenicosan-21-oate; 3,6,9,12,15,18-Hexaoxahen DNP-PEG8-DNP Formula: C30H44N6O16 GëÑ95% BPG-1612 N1,N26-bis(2,4-dinitrophenyl)-3,6,9,12,15,18,21,24-octaoxahexacosane-1,26-diamine DNP-PEG9-DNP CAS:190792-09-7 Formula: C32H48N6O17 GëÑ95% BPG-0200 N1,N29-bis(2,4-dinitrophenyl)-3,6,9,12,15,18,21,24,27-nonaoxanonacosane-1,29-diamine DNP-PEG9-NH2 CAS:2187509-51-7 Formula: C26H46N4O13 GëÑ95% BPG-1639 N1-(2,4-Dinitrophenyl)-3,6,9,12,15,18,21,24,27-nonaoxanonacosane-1,29-diamine DNP-PEG9-NHBoc Formula: C31H54N4O15 GëÑ95% BPG-1649 tert-Butyl (2-(2-(2-(2-(2-(2-(2-(2-(2-(2-((2,4-dinitrophenyl)amino)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethyl)carbamate; tert-butyl (29-((2,4-dinitrophenyl)amino)-3,6,9,12,15,18,21,24,27-nonaoxanonacosyl)carbamate DNP-PEG9-NHS ester Formula: C31H48N4O17 GëÑ95% BPG-1659 2,5-dioxopyrrolidin-1-yl 1-((2,4-dinitrophenyl)amino)-3,6,9,12,15,18,21,24,27-nonaoxatriacontan-30-oate DO3A CAS:217973-03-0 Formula: C14H23N4O6-+3(Na) BB063150 Trisodium 1,4,7,10-Tetraazacyclododecane-1,4,7-triacetate; 1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic Acid Trisodium Salt DO3A TERT-BUTYL ESTER CAS:122555-91-3 Formula: C26H50N4O6 >98% BAT-010898 Tri-tert-butyl 1,4,7,10-tetraazacyclododecane-1,4,7-triacetate; DO3A-t-Bu-ester; 1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic Acid Tri-tert-butyl Ester DOCETAXAL 2'-TERT-BUTYLDIMETHYLSILYL ETHER CAS:1144034-14-9 Formula: C51H69NO15Si BB066604 (+¦R,+¦S)-+¦-[[(1,1-Dimethylethoxy)carbonyl]amino]-+¦-[[(1,1-dimethylethyl)dimethylsilyl]oxy]benzenepropanoic Acid (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-Bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihyd DOCETAXEL 2',7,10-TRIS(TRIETHYLSILYL) ETHER CAS:149107-86-8 Formula: C61H95NO14Si3 GëÑ95% 149107-86-8 2',7,10-Tris(triethylsilyl)docetaxel; [2aR-[2a+¦,4+¦,4a+¦,6+¦,9+¦(+¦R*,+¦S*),11+¦,12+¦,12a+¦,12b+¦]]-+¦-[[(1,1-Dimethylethoxy)carbonyl]amino]-+¦-[(triethylsilyl)oxy]-benzenepropanoic Acid 12b-(Acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b- DOCETAXEL 2'-TERT-BUTYLDIMETHYLSILYL 7,10-TRIS(TRIETHYLSILYL) ETHER CAS:195141-96-9 Formula: C61H95NO14Si3 BB068636 (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(Acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-11-hydroxy-4a,8,13,13-tetramethyl-5-oxo-4,6-bis[(triethylsilyl)oxy]-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl (+¦R,+¦S) DOCETAXEL HYDRATE CAS:700367-34-6 Formula: C43H53NO14.xH2O 700367-34-6 (+¦R,+¦S)-+¦-[[(1,1-Dimethylethoxy)carbonyl]amino]-+¦-hydroxybenzenepropanoic Acid(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(Acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7 DOCETAXEL HYDROXY TERT-BUTYLCARBAMATE CAS:154044-57-2 Formula: C43H53NO15 GëÑ95% 154044-57-2 Docetaxel Metabolite M2; RPR-104952; Benzenepropanoic acid, +¦-hydroxy-+¦-[[(2-hydroxy-1,1-dimethylethoxy)carbonyl]amino]-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6, DOCETAXEL IMPURITY 1 CAS:158810-73-2 Formula: C46H55Cl2NO16 > 95% 158810-73-2 (+¦R,+¦S)-+¦-[[(1,1-Dimethylethoxy)carbonyl]amino]-+¦-hydroxybenzenepropanoic Acid (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(Acetyloxy)-12-(benzoyloxy)-6-[[(2,2-dichloroethoxy)carbonyl]oxy]-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihy DOCETAXEL IMPURITY 2 CAS:158810-72-1 Formula: C46H55Cl2NO16 > 95% 158810-72-1 Benzenepropanoic acid, -[[(1,1-dimethylethoxy)carbonyl]amino]--hydroxy-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-4-[[(2,2-dichloroethoxy)carbonyl]oxy]-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-6,11-dihydroxy- DOCETAXEL IMPURITY 3 CAS:172018-16-5 Formula: C29H36O10 > 95% 172018-16-5 13-epi-10-Deacetyl Baccatin III; [2aR-(2a+¦,4+¦,4a+¦,6+¦,9+¦,11+¦,12+¦,12a+¦,12b+¦)]-12b-(Acetyloxy)-12-(benzoyloxy)-1,2a,3,4,4a,6,9,10,11,12,12a,12b-dodecahydro-4,6,9,11-tetrahydroxy-4a,8,13,13-tetramethyl-7,11-methano-5H-cyclodeca[3,4]benz[1,2-b]o DOCETAXEL METABOLITE M4 CAS:157067-34-0 Formula: C43H49NO15 95% 157067-34-0 RPR 104943; (2+¦,5+¦,7+¦,10+¦,13+¦)-4-Acetoxy-13-{[(2R,3S)-3-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-2-hydroxy-3-phenylpropanoyl]oxy}-1,7,10-trihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate; 3-Oxazolidinepropanoic acid, +¦-hydroxy-5,5-dime DOCETAXEL TRIHYDRATE CAS:148408-66-6 Formula: C43H53NO14.3(H2O) 98% 148408-66-6 7,11-Methano-1H-cyclodeca[3,4]benz[1,2-b]oxete Benzenepropanoic Acid Deriv.; [2aR-[2a+¦,4+¦,4a+¦,6+¦,9+¦(+¦R*,+¦S*),11+¦,12+¦,12a+¦,12b+¦]]-12b-(Acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetra DOCETAXEL-[D5] Formula: C43H48D5NO14 GëÑ97%; GëÑ98% atom D BLP-007881 Docetaxel-d5; (+¦R,+¦S)-+¦-[[(1,1-Dimethylethoxy)carbonyl]amino]-+¦-hydroxybenzenepropanoic Acid (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(Acetyloxy)-12-(benzoyloxy-d5)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-t Docetaxel-[d5] 2',7,10-Tris(triethylsilyl) Ether Formula: C61H90D5NO14Si3 >95% BLP-015025 Benzenepropanoic acid-d5, +¦-[[(1,1-dimethylethoxy)carbonyl]amino]-+¦-[(triethylsilyl)oxy]-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-11-hydroxy-4a,8,13,13-tetramethyl-5 DOCOSAHEXAENOIC ACID CAS:6217-54-5 Formula: C22H32O2 98% BBF-05818 (all-Z)-4,7,10,13,16,19-Docosahexaenoic Acid; DHA; Cervonic Acid; Doconexent; cis-4,7,10,13,16,19-Docosahexaenoic acid; all-cis-DHA; all-Z-Docosahexaenoic acid; (4Z,7Z,10Z,13Z,16Z,19Z)-Docosahexaenoic acid; all-cis-docosa-4,7,10,13,16,19-he DOCOSAHEXAENOIC ACID METHYL ESTER-[21,21,22,22,22-D5] Formula: C23H29D5O2 97% by CP; 98% atom D BLP-007402 docosahexaenoic acid, methyl ester (21,21,22,22,22-D5); cis-4,7,10,13,16,19-Docosahexaenoic Acid Methyl Ester-D5 DOCOSAHEXAENOIC ACID N-SUCCINIMIDE CAS:160801-26-3 Formula: C26H35NO4 BPG-3848 Docosahexaenoic Acid N-Succinimide; 160801-26-3; (2,5-dioxopyrrolidin-1-yl) (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate; 2,5-Dioxopyrrolidin-1-yl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate; SCHEMBL25542892; BP-2 DOCOSANOIC ACID-[12,12,13,13-D4] CAS:1219804-98-4 Formula: C22H40D4O2 98% by CP; 98% atom D BLP-007405 Docosanoic acid 12,12,13,13-D4; Docosanoic-12,12,13,13-d4 acid; 1-Docosanoic Acid-12,12,13,13-d4; NSC 32364-d4; Behenic Acid-12,12,13,13-d4 DOCOSAPENTAENOIC ACID-[D5] CAS:1215168-70-9 Formula: C22H29D5O2 95% by CP; 99% atom D BLP-005213 Docosapentaenoic Acid D5; (all-cis)-7,10,13,16,19-Docosapentaenoic-d5 Acid; (7Z,10Z,13Z,16Z,19Z)-7,10,13,16,19-Docosapentaenoic-d5 Acid; (all-Z)-7,10,13,16,19-Docosapentaenoic-d5 Acid DODECABORATE(2-),1,2,3,4,5,6,7,8,9,10,11-UNDECAHYDRO-12-MERCAPTO-, SODIUM (1:2) CAS:144885-51-8 Formula: B12H12 S . 2 Na 98% 144885-51-8 DODECAETHYLENE GLYCOL CAS:6790-09-6 Formula: C24H50O13 GëÑ95% 6790-09-6 HO-PEG12-OH; 3,6,9,12,15,18,21,24,27,30,33-Undecaoxapentatriacontane-1,35-diol; Dodecaethyleneglycol Dodecaethylene glycol di(p-toluenesulfonate) CAS:1456708-45-4 Formula: C38H62O17S2 GëÑ95% BP-501391 Tos-PEG13-Tos; Tos-PEG12-Tos; p-Toluenesulfonic acid 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(tosyloxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl ester; 3,6,9,12,15,18,21,24,27,30,33-Undecaoxapentatriacont Dodecaethylene glycol dimethanesulfonate CAS:2701516-10-9 Formula: C26H54O17S2 GëÑ95% BPG-0539 Ms-PEG13-Ms; Ms-PEG12-Ms; 3,6,9,12,15,18,21,24,27,30,33-Undecaoxapentatriacontane-1,35-diol, 1,35-dimethanesulfonate; 3,6,9,12,15,18,21,24,27,30,33-Undecaoxapentatriacontane-1,35-diyl dimethanesulfonate DODECAHYDRO-1,4:5,8-DIMETHANOANTHRACENE-9,10-DIONE CAS:66513-31-3 Formula: C16H20O2 BB033046 pentacyclo[10.2.1.1^{5,8}.0^{2,11}.0^{4,9}]hexadecane-3,10-dione; pentacyclo[10.2.1.1^{5,8}.0^{2,11}.0^{4,9}]hexadecane-3,10-dione DODECAMETHYLPENTASILOXANE CAS:141-63-9 Formula: C12H36O4Si5 141-63-9 1,1,1,3,3,5,5,7,7,9,9,9-Dodecamethylpentasiloxane; dodecamethyl pentasiloxane DODECYL 2-ACETAMIDO-3,4,6-TRI-O-ACETYL-2-DEOXY-B-D-GLUCOPYRANOSIDE CAS:211567-22-5 Formula: C26H45NO9 211567-22-5 +¦-D-Glucopyranoside, dodecyl 2-(acetylamino)-2-deoxy-, 3,4,6-triacetate; (2R,3S,4R,5R,6R)-5-Acetamido-2-(acetoxymethyl)-6-(dodecyloxy)tetrahydro-2H-pyran-3,4-diyl diacetate; Dodecyl 2-(acetylamino)-2-deoxy-3,4,6-triacetate +¦-D-Glucopyranosi DODOVISLACTONE B CAS:1616683-55-6 Formula: C21H30O5 NP1600 Dodovislactone B; 1616683-55-6; (4Ar,5S,6R,8aR)-5-[2-(2-methoxy-5-oxo-2H-furan-3-yl)ethyl]-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalene-1-carboxylic acid DOLICHORRHIZIN CAS:3607-97-4 Formula: C32H54O3 BBF-05341 15+¦-Acetyloxyhopan-22-ol; Hopane-15+¦,22-diol 15-acetate; Acetic acid (3S,3aS,5S,5aR,5bR,11aS,13aR,13bS)-3-(1-hydroxy-1-methyl-ethyl)-5a,5b,8,8,11a,13b-hexamethyl-icosahydro-cyclopenta[a]chrysen-5-yl ester Dolutegravir-[6,6,7-d3] Formula: C20H6D3F2N3O5 >95%; 98% atom D BLP-013426 Tivicay-d3; (4R,12aS)-N-(2,4-difluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2',4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide-d3 DOLUTEGRAVIR-[D3] CAS:2673270-25-0 Formula: C20H18D3F2N3O4 95% by CP; 98% atom D BLP-006067 (4R,12aS)-N-((2,4-difluorophenyl-3-d)methyl-d2)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide; Dolutegravir D3; Dolutegravir-d3; GSK 1349572-d3; S/GSK1349572-d3; Soltegra DOLUTEGRAVIR-[D4] Formula: C20H15D4F2N3O5 BLP-005217 (4R,12aS)-N-[(2,4-Difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide-d4; Dolutegravir-d4 DOLUTEGRAVIR-[D6] CAS:1407166-95-3 Formula: C20H13D6F2N3O5 98%; 98% atom D BLP-013858 Dolutegravir-d6; (4R,12aS)-N-[(2,4-Difluorophenyl)methyl-d2]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-(methyl-d3)-6,8-dioxo-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-4-d-9-carboxamide DOLUTEGRAVIR-D5 Formula: C20H14D5F2N3O5 GëÑ99% atom D BLP-015145 (4R,12aS)-N-((2,4-difluorophenyl-3,5,6-d3)methyl-d2)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide DOT1L-IN-6 CAS:2565705-01-1 Formula: C25H21ClF2N6O6S 2565705-01-1 1,2-Benzenediamine, N1-[(S)-(3-chloro-2-pyridinyl)(2,2-difluoro-1,3-benzodioxol-4-yl)methyl]-N2-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-(methylsulfonyl)-; N1-[(S)-(3-Chloro-2-pyridinyl)(2,2-difluoro-1,3-benzodioxol-4-yl)methyl]-N2-(4,6-dimetho DOTA(ALLYL ESTER)3 Formula: C25H40N4O8 BAT-014798 DOTA(OAll)3; 4,7,10-Tri-(allyloxycarbonylmethyl)-1,4,7,10-tetraazacyclododecan-1-yl-acetic acid; 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid 1,4,7-triallyl ester; 2-(4,7,10-tris(2-(allyloxy)-2-oxoethyl)-1,4,7,10-tetraazacyclodo DOTA-NHS-ESTER HEXAFLUOROPHOSPHATE TFA SALT (TECHNICAL GRADE) CAS:1823122-52-6 Formula: C20H31N5O10-+C2HF3O2-+HPF6 BB063147 1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid mono(N-hydroxysuccinimidyl) ester Hexafluorophosphate TFA Salt; 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid mono(N-hydroxysuccinimide ester) Hexafluorophosphate TFA DOTA-NHS-ester TFA Salt CAS:2832911-57-4 Formula: C20H31N5O10.4C2HF3O2 GëÑ95% BADC-01343 DOTA-NHS-ester (trifluoroacetic acid salt); 1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid mono(N-hydroxysuccinimidyl) ester TFA Salt; 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid mono(N-hydroxysuccinimide ester) DOTA-PEG5-NH2 hydrochloride Formula: C28H54N6O12.HCl GëÑ95% BP-502129 DOTA-PEG5-amine HCl salt; NH2-PEG5-DOTA HCl salt; DOTA-PEG5-amine HCl salt; DOTA-polyethylene glycol-5-amine HCl salt; 2,2',2''-(10-(20-Amino-2-oxo-6,9,12,15,18-pentaoxa-3-azaicosyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetic acid DOTA-TRIS(TERT-BUTYL ESTER) CAS:137076-54-1 Formula: C28H52N4O8 95% BAT-009048 Tri-tert-butyl 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetate; DOTA tri(tert-butyl) ester; DOTA(OBu-t)3; Tri-tert-Bu-DOTA; 2-(4,7,10-Tris(2-(tert-butoxy)-2-oxoethyl)-1,4,7,10-tetraazacyclododecan-1-yl)acetic acid; DOTA(OtBu); 1,4,7,10 Dotatate CAS:177943-88-3 Formula: C65H90N14O19S2 GëÑ95% 177943-88-3 L-Threonine, N-[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-threonyl-L-cysteinyl-, cyclic (2GåÆ7)-disulfide; L-Threonine, N-[[4,7,10-tris(carboxymethyl)-1, DOTMA TETRASODIUM CAS:1325214-86-5 Formula: C20H32N4Na4O8 BB063149 (1R,4R,7R,10R)-+¦,+¦',+¦'',+¦'''-Tetramethyl-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid tetrasodium salt DOXO-EMCH CAS:151038-96-9 Formula: C37H42N4O13 >98% BADC-00028 1H-Pyrrole-1-hexanoic acid, 2,5-dihydro-2,5-dioxo-, [1-[(2S,4S)-4-[(3-amino-2,3,6-trideoxy-+¦-L-lyxo-hexopyranosyl)oxy]-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-2-naphthacenyl]-2-hydroxyethylidene]hydrazide; 1H-Pyrrole-1 DOXOFYLLINE IMPURITY 5 Formula: C11H12N4O4 >98% 2,4(1H,3H)-Dione, 1,3-dimethyl-6,7,9,10-tetrahydro-7,10-epoxy[1,4]oxazepino[5,4-f]purine- DOXORUBICIN DIMER IMPURITY 1 Formula: C54H56N2O21 GëÑ95% (8S,10S)-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(((2S,3S,4S,6R)-3-hydroxy-2-methyl-6-(((1S,3S)-3,5,12-trihydroxy-3-(2-hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetrace DOXORUBICIN DIMER IMPURITY 3 Formula: C54H58N2O22 (8S,8'S,10S,10'S)-8,8'-(4-Hydroxy-2-(hydroxymethyl)-1,3-dioxolane-2,4-diyl)bis(10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione); (R,S,S,S,8S,8'S, DOXORUBICIN EP IMPURITY B CAS:106401-68-7 Formula: C29H34BrNO11 85% 106401-68-7 Doxorubicin Impurity B; Doxorubicin Ketal Impurity; (8S,10S)-10-[(3-Amino-2,3,6-trideoxy-+¦-L-lyxo-hexopyranosyl)oxy]-8-(2-bromo-1,1-dimethoxyethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione; 14-bromine-13-dimethy Doxorubicin EP Impurity C hydrobromide dihydrate Formula: C27H28BrNO10.2H2O.HBr (8S,10S)-10-[(3-Amino-2,3,6-trideoxy-+¦-L-lyxo-hexopyranosyl)oxy]-8-(bromoacetyl)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione dihydrate hydrobromide; (8S,10S)-10-[(3-Amino-2,3,6-trideoxy-+¦-L-lyxo-hexopyranosyl)oxy]-8- DOXORUBICIN IMPURITY 1 CAS:1159977-24-8 Formula: C19H12O7 > 95% 1159977-24-8 Doxorubicin Impurity; 6,8,10,11-Tetrahydroxy-1-methoxy-5,12-naphthacenedione; 7,8-Desacetyl-9,10-dehydro Daunorubicinone; 5,12-Naphthacenedione, 6,8,10,11-tetrahydroxy-1-methoxy-; Xanthone Impurity 13 DOXORUBICIN IMPURITY 13 Formula: C27H29NO12 (8R,10S)-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,7,8,11-tetrahydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione Doxorubicin Impurity 15 HBr Formula: C31H38BrNO11.HBr (8S-cis)-10-[(3-Amino-2,3,6-trideoxy-+¦-L-lyxo-hexopyranosyl)oxy]-8-(2-bromo-1,1-diethoxyethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione Hydrobromide; (7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl] DOXORUBICIN IMPURITY 16 TRIFLUOROACETATE Formula: C37H42N4O13.C2HF3O2 Aldoxorubicin Trifluoroacetate; Doxorubicin-EMCH Trifluoroacetate; DOXO-EMCH Trifluoroacetate; N'-[(1E)-1-{(2S,4S)-4-[(3-Amino-2,3,6-trideoxy-+¦-L-lyxo-hexopyranosyl)oxy]-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-2-tetrac DOXORUBICIN IMPURITY 18 CAS:59325-97-2 Formula: C19H14O6 GëÑ95% 59325-97-2 5,12-Dihydroxy-7-methoxy-3,4-dihydrotetracene-2,6,11(1H)-trione; 4-Methoxy-6,11-dihydroxy-7,8-dihydro-5,9(10H),12-naphthacenetrione; 6,11-dihydroxy-4-methoxy-7,8,9,10-tetrahydronaphthacene-5,9,12-trione Doxorubicin Impurity 19Q CAS:201278-93-5 Formula: C54H54N2O21 201278-93-5 (8S,10S)-10-(((2R,4S,5S,6S)-4-Amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-(((2S,3S,4S,6R)-3-hydroxy-2-methyl-6-(((1S,3S)-3,5,12-trihydroxy-3-(2-hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetr DOXORUBICIN IMPURITY 2 CAS:64845-67-6 Formula: C19H12O6 >95% 64845-67-6 Doxorubicin Impurity-Gàí; 6,8,11-Trihydroxy-1-methoxy-5,12-naphthacenedione; 5,12-Naphthacenedione, 6,8,11-trihydroxy-1-methoxy-; 7,8-Dehydro-9,10-desacetyldoxorubicinone; 7,8-Dhda-DR; 1-Methoxy-6,8,11-trihydroxynaphthacene-5,12-dione DOXORUBICIN IMPURITY 22 Formula: C20H12O7 95% Methyl 5,7,12-trihydroxy-6,11-dioxo-6,11-dihydrotetracene-2-carboxylate; Methyl 5,7,12-trihydroxy-6,11-dioxo-6,11-dihydro-2-tetracenecarboxylate; 2-Naphthacenecarboxylic acid, 6,11-dihydro-5,7,12-trihydroxy-6,11-dioxo-, methyl ester DOXORUBICIN IMPURITY 23 CAS:73952-94-0 Formula: C27H29NO10.HCl GëÑ95% 73952-94-0 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-+¦-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-8,11-dihydroxy-8-(2-hydroxyacetyl)-1-methoxy-, hydrochloride (1:1), (8S,10S)-; 11-Deoxydoxorubicin Hydrochloride; (1S,3S)-3-Glycoloyl-3,12-di DOXORUBICIN IMPURITY 24 CAS:117903-06-7 Formula: C27H27NO11 117903-06-7 2-Naphthaceneacetaldehyde, 4-[(3-amino-2,3,6-trideoxy-+¦-L-lyxo-hexopyranosyl)oxy]-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-+¦,6,11-trioxo-, (2S,4S)-; (2S,4S)-4-[(3-Amino-2,3,6-trideoxy-+¦-L-lyxo-hexopyranosyl)oxy]-1,2,3,4,6,11-hexah DOXORUBICIN IMPURITY 25 Formula: C27H29NO12.HCl 2-Naphthaceneacetic acid, 4-[(3-amino-2,3,6-trideoxy-+¦-L-lyxo-hexopyranosyl)oxy]-1,2,3,4,6,11-hexahydro-+¦,2,5,12-tetrahydroxy-7-methoxy-6,11-dioxo-, (2S,4S)-, hydrochloride (1:1); (2S,4S)-4-[(3-Amino-2,3,6-trideoxy-+¦-L-lyxo-hexopyranosyl)ox DOXORUBICIN IMPURITY 26 CAS:189289-22-3 Formula: C27H29NO12 GëÑ95% 189289-22-3 2-Naphthaceneacetic acid, 4-[(3-amino-2,3,6-trideoxy-+¦-L-lyxo-hexopyranosyl)oxy]-1,2,3,4,6,11-hexahydro-+¦,2,5,12-tetrahydroxy-7-methoxy-6,11-dioxo-, (2S,4S)-; (2S,4S)-4-[(3-Amino-2,3,6-trideoxy-+¦-L-lyxo-hexopyranosyl)oxy]-1,2,3,4,6,11-hexah DOXORUBICIN IMPURITY 3 Formula: C20H12O7 5,12-Dihydroxy-7-methoxy-6,11-dioxo-6,11-dihydrotetracene-2-carboxylic acid; 5,12-Dihydroxy-7-methoxy-6,11-dioxo-6,11-dihydro-2-tetracenecarboxylic acid; 2-Naphthacenecarboxylic acid, 6,11-dihydro-5,12-dihydroxy-7-methoxy-6,11-dioxo- Doxorubicin Impurity 30 CAS:90410-90-5 Formula: C22H20O8 GëÑ95% 90410-90-5 5,12-Naphthacenedione, 8-acetyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1,10-dimethoxy-, (8S-trans)-; (8S,10R)-8-acetyl-6,8,11-trihydroxy-1,10-dimethoxy-7,8,9,10-tetrahydrotetracene-5,12-dione Doxorubicin Impurity 31 Formula: C22H20O8 5,12-Naphthacenedione, 8-acetyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1,10-dimethoxy-, (8S-cis)-; (8S,10S)-8-acetyl-6,8,11-trihydroxy-1,10-dimethoxy-7,8,9,10-tetrahydrotetracene-5,12-dione Doxorubicin Impurity 32 CAS:32384-98-8 Formula: C21H18O7 95% 32384-98-8 7-Deoxydaunomycinone; 5,12-Naphthacenedione,8-acetyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8R)-; 7-Deoxydaunorbicin aglycone; (R)-8-acetyl-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione; 10-Deoxydaunomycino Doxorubicin Impurity 33 CAS:59325-98-3 Formula: C21H18O8 GëÑ95% 59325-98-3 5,12-Naphthacenedione, 8-acetyl-7,8,9,10-tetrahydro-6,8,10,11-tetrahydroxy-1-methoxy-, (8S,10R)-; (8S,10R)-8-Acetyl-6,8,10,11-tetrahydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione; 5,12-Naphthacenedione, 8-acetyl-7,8,9,10-tetrahydr Doxorubicin Impurity 35 Formula: C28H31NO12 (8S,10S)-6,8,11-trihydroxy-10-(((2R,4S,5S,6S)-5-hydroxy-4-((hydroxymethyl)amino)-6-methyltetrahydro-2H-pyran-2-yl)oxy)-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione DOXORUBICIN IMPURITY 6 CAS:69429-21-6 Formula: C26H27NO11 >95% 69429-21-6 9-Carboxy Doxorubicin Impurity; (2S,4S)-4-(((2R,4S,5S,6S)-4-Amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracene-2-carboxylic acid; (2S,4S)-4-[(3-Amino-2,3,6-trideoxy-+¦ DOXORUBICIN IMPURITY 7 CAS:1159977-23-7 Formula: C21H14O8 > 95% 1159977-23-7 7,8,9,10-Dehydro Doxorubicinone; 8-Glycoloyl-6,10,11-trihydroxy-1-methoxy-5,12-tetracenedione; 5,12-Naphthacenedione, 6,10,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-; 6,10,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxytetracene-5,12-dione DOXORUBICIN-SMCC CAS:400647-59-8 Formula: C39H42N2O14 >99.3% BADC-01122 4-((2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)methyl)-N-((2S,3S,4S,6R)-3-hydroxy-2-methyl-6-(((1S,3S)-3,5,12-trihydroxy-3-(2-hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl)oxy)tetrahydro-2H-pyran-4-yl)cyclohexanecarboxa DOXORUBICINOL CAS:54193-28-1 Formula: C27H31NO11 GëÑ95% 54193-28-1 Adriamycinol; 13-Dihydrodoxorubicin; Antibiotic 27706RP; RP 27706; (1S,3S)-3-[(1S)-1,2-Dihydroxyethyl]-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-1-tetracenyl 3-amino-2,3,6-trideoxy-+¦-L-lyxo-hexopyranoside; 5,12-Naphthac Doxorubicinol (>90%)(Mixture of Diastereomers) Formula: C27H31NO11 BB063174 [8S-[8+¦,8(R*),10+¦]]-10-[(3-Amino-2,3,6-trideoxy-+¦-L-lyxo-hexopyranosyl)oxy]-8-(1,2-dihydroxyethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione; 13-Dihydrodoxorubicin; Adriamycinol; Antibiotic 27706RP; RP 27706 Doxorubicinol (Mixture of Diastereomers) Formula: C27H31NO11 >90% [8S-[8+¦,8(R*),10+¦]]-10-[(3-Amino-2,3,6-trideoxy-+¦-L-lyxo-hexopyranosyl)oxy]-8-(1,2-dihydroxyethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione; (1S,3S)-3-(1,2-Dihydroxyethyl)-3,5,12-trihydroxy-10-methoxy-6,11-dioxo DOXORUBICINOL CITRATE Formula: C27H31NO11.C6H8O7 Adriamycinol Citrate; 13-Dihydrodoxorubicin Citrate; Antibiotic 27706RP Citrate; RP 27706 Citrate; (1S,3S)-3-[(1S)-1,2-Dihydroxyethyl]-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-1-tetracenyl 3-amino-2,3,6-trideoxy-+¦-L-ly DOXORUBICINOL CITRATE (MIXTURE OF DIASTEREOMERS) Formula: C27H31NO11.C6H8O7 [8S-[8+¦,8(R*),10+¦]]-10-[(3-Amino-2,3,6-trideoxy-+¦-L-lyxo-hexopyranosyl)oxy]-8-(1,2-dihydroxyethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione Citrate; (1S,3S)-3-(1,2-Dihydroxyethyl)-3,5,12-trihydroxy-10-methoxy-6, DOXORUBICINOL HYDROCHLORIDE CAS:63950-05-0 Formula: C27H32ClNO11 GëÑ90% BBF-04065 (8S,10S)-10-[(3-Amino-2,3,6-trideoxy-+¦-L-lyxo-hexopyranosyl)oxy]-8-[(1S)-1,2-dihydroxyethyl]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione Hydrochloride; Adriamycinol Hydrochloride; 13-Dihydrodoxorubicin Hydrochlorid Doxorubicinol Hydrochloride (Mixture of Diasteromers) Formula: C27H31NO11.HCl 90% (8S,10S)-10-(((2R,4S,5S,6S)-4-Amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-8-(1,2-dihydroxyethyl)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione, hydrochloride (1:1); Doxorubicinol HCl (Mixture of Diasteromers) DOXORUBICINOL TFA SALT Formula: C27H31NO11.CF3CO2H GëÑ95% Adriamycinol trifluoroacetic acid; 13-Dihydrodoxorubicin trifluoroacetic acid; Antibiotic 27706RP trifluoroacetic acid; RP 27706 trifluoroacetic acid; (1S,3S)-3-[(1S)-1,2-Dihydroxyethyl]-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11- DOXORUBICINOLONE (MIXTURE OF DIASTEREOMERS) CAS:210837-88-0 Formula: C21H20O9 GëÑ95% 210837-88-0 (8S,10S)-8-(1,2-Dihydroxyethyl)-7,8,9,10-tetrahydro-6,8,10,11-tetrahydroxy-1-methoxy-5,12-naphthacenedione; (8S,10S)-8-(1,2-Dihydroxyethyl)-6,8,10,11-tetrahydroxy-1-methoxy-7,8,9,10-tetrahydro-5,12-tetracenedione; 5,12-Naphthacenedione, 8-( DOXORUBICINONE CAS:24385-10-2 Formula: C21H18O9 GëÑ95% B0805-470478 (8S,10S)-7,8,9,10-Tetrahydro-6,8,10,11-tetrahydroxy-8-(2-hydroxyacetyl)-1-methoxy-5,12-naphthacenedione; Adriamycin Aglycone; Adriamycinone; Doxorubicin Aglycone; Epirubicin Aglycone; 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,10,11-tet DOXORUBICINONE VALERATE CAS:158699-93-5 Formula: C26H26O10 158699-93-5 Valrubicin impurity, doxorubicinone valerate [USP]; 2-Oxo-2-((2S,4S)-2,4,5,12-tetrahydroxy-7-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-2-yl)ethyl pentanoate; Pentanoic acid, 2-(1,2,3,4,6,11-hexahydro-2,4,5,12-tetrahydroxy-7-methoxy- DOXYCYCLINE 5-SULFOSALICYLATE CAS:60683-15-0 Formula: C29H30N2O14S 60683-15-0 2-Hydroxy-5-sulfobenzoic acid (4S,4aR,5S,5aR,6R,12aS)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-2-tetracenecarboxamide (1:1); Benzoic acid, 2-hydroxy-5-sulfo-, compd. with (4S,4aR,5S,5aR DOXYCYCLINE CALCIUM CAS:94088-85-4 Formula: C22H24N2O8.2Ca 94088-85-4 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, calcium salt (1:2), [4S-(4+¦,4a+¦,5+¦,5a+¦,6+¦,12a+¦)]-; 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a- DOXYCYCLINE EP IMPURITY A CAS:3219-99-6 Formula: C22H24N2O8 GëÑ95% BBF-01824 6-Epidoxycycline; Doxycycline hyclate EP impurity A; Doxycycline monohydrate EP impurity A; 6+¦-Deoxy-5-hydroxytetracycline; 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11- Doxycycline EP Impurity A hydrochloride CAS:41411-66-9 Formula: C22H25ClN2O8 95% 41411-66-9 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, [4S-(4+¦,4a+¦,5+¦,5a+¦,6+¦,12a+¦)]-; 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-o DOXYCYCLINE EP IMPURITY B CAS:914-00-1 Formula: C22H22N2O8 >98% by HPLC BBF-03960 Doxycycline hyclate EP impurity B; Doxycycline monohydrate EP impurity B; 6-Methyleneoxytetracycline; Metacycline; Rondomycin; 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methylene DOXYCYCLINE EP IMPURITY C CAS:6543-77-7 Formula: C22H24N2O8 GëÑ95% 6543-77-7 Doxycycline hyclate EP impurity C; Doxycycline monohydrate EP impurity C; 4-Epidoxycycline; 4-epi-Doxycycline; (4R,4aR,5S,5aR,6R,12aS)-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphtha DOXYCYCLINE EP IMPURITY D CAS:97583-08-9 Formula: C22H24N2O8 GëÑ95% 97583-08-9 Doxycycline hyclate EP impurity D; Doxycycline monohydrate EP impurity D; 4-epi-6-Epidoxycycline; Doxycycline impurity D; 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-di DOXYCYCLINE EP IMPURITY F CAS:122861-53-4 Formula: C23H25NO8 90% B2694-470498 Doxycycline hyclate EP impurity F; Doxycycline monohydrate EP impurity F; 2-Acetyl-2-decarbamoyldoxycycline; 1,11(4H,5H)-Naphthacenedione, 2-acetyl-4-(dimethylamino)-4a,5a,6,12a-tetrahydro-3,5,10,12,12a-pentahydroxy-6-methyl-, (4S,4aR,5S,5a DOXYCYCLINE HYCLATE CAS:24390-14-5 Formula: C23H29ClN2O9 Assayn+Ü800 - 920 ++g/mg B2693-462924 (4S,4aR,5S,5aR,6R,12aS)-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide Hyclate; Doxinyl; Doxivetin; Doxycen; GS 3065; Hydramycin; Liviatin; Doxycycline Hydrochloride |